Toggle Offcanvas
...
Global Government Tenders

Most trusted source for Tendering Opportunities and Business Intelligence since 2002

Open House Pharmaceutical Dact Treaties Formoterol, Glycopyrronium Bromide And Budesonide, Atc R03Al11

AOK Bayern - Die Gesundheitskasse Germany has Released a tender for Open House Pharmaceutical Dact Treaties Formoterol, Glycopyrronium Bromide And Budesonide, Atc R03Al11 in Pharmaceuticals. The tender was released on May 16, 2025.

Country - Germany

Summary - Open House Pharmaceutical Dact Treaties Formoterol, Glycopyrronium Bromide And Budesonide, Atc R03Al11

Deadline - May 05, 2027

GT reference number - 109039325

Product classification - Pharmaceutical products

Organization Details:

  Address - Germany

  Contact details - 565656565

  Tender notice no. - 76454545

  GT Ref Id - 109039325

  Document Type - Tender Notices

Notice Details and Documents:

Description - Description: It is not an open procedure, but a so-called open-house model! The form for the open procedure is only used because there is no form for the open house model. Contracts that are concluded in the open house model are not subject to procur ement law due to a lack of selection decision. A submission under public procurement regulations is not connected to the use of this form. AOK Bayern intends to close non-exclusive discount agreements on the active ingredient formoterol, glycopyrronium bromide and Budesonide, ATC R03al11, according to Section 130a (8) SGB V with all interested pharmaceutical companies. AOK Bayern offers all interested pharmaceutical companies that meet the equiva

Gt Ref Id - 109039325

Deadline - May 05, 2027

Share share

Similar Tenders :

Summary:
Create Account

Why Us

3,00,000 +

Users

190 +

Countries Covered

5,00,000 +

Agencies Tracked

50,000 +

Notices Daily

90 Million +

Database